Cardiothoracic Surgery

Learning Objectives

By the end of this topic, you should be able to:

• Explain the indications for coronary artery bypass grafting (CABG) and describe how the procedure is performed
• Compare the choice of graft conduits (LIMA, saphenous vein, radial artery) and why conduit choice affects long-term patency
• Differentiate valve repair from valve replacement, and mechanical from bioprosthetic valves, including anticoagulation implications
• Outline the surgical approach to lung cancer, including lobectomy, pneumonectomy, and segmentectomy
• Recognize the role of cardiopulmonary bypass and cardioplegia in protecting the heart during open procedures
• Identify major postoperative complications after cardiothoracic surgery and how they are anticipated

Quick Answer

Cardiothoracic surgery treats structural disease of the heart, great vessels, and lungs through open or minimally invasive operations. The three procedures every student must know cold are CABG (restoring blood flow around blocked coronary arteries using a graft, most commonly the left internal mammary artery), valve surgery (repairing or replacing a diseased valve, usually mitral or aortic), and pulmonary resection for lung cancer (removing the tumor-bearing lobe or lung with adequate margins and lymph node sampling). It matters because ischemic heart disease, valvular disease, and lung cancer are leading causes of morbidity and mortality worldwide, and surgery — not medication alone — is often what changes survival.

CABG (Coronary Artery Bypass Grafting)

CABG restores blood flow to heart muscle that is starved because of blocked coronary arteries. Think of it as building a detour around a traffic jam: the graft doesn't clear the blockage, it routes blood around it.

Indications: left main coronary artery stenosis >50%, triple-vessel disease (especially with reduced ejection fraction or diabetes), and disease not amenable to percutaneous coronary intervention (PCI). The SYNTAX trial and related evidence generally favor CABG over PCI for anatomically complex multivessel disease.

Conduits and why they matter: the left internal mammary artery (LIMA) grafted to the left anterior descending artery (LAD) is the gold standard — it has a 90%+ patency rate at 10 years because arterial grafts resist atherosclerosis better than veins. The great saphenous vein is used for additional grafts but has a lower patency (roughly 50-60% at 10 years) because vein grafts are prone to intimal hyperplasia and later atherosclerosis. The radial artery is a second arterial option with better durability than vein but is prone to spasm, so patients are given calcium channel blockers postoperatively.

On-pump vs off-pump: traditional CABG uses cardiopulmonary bypass (the heart-lung machine) plus cardioplegia (a potassium-rich solution that stops the heart in diastole) to create a still, bloodless field. Off-pump CABG (OPCAB) uses a mechanical stabilizer to operate on a beating heart, avoiding bypass-related complications like stroke and inflammatory response, but it is technically more demanding.

Valve Surgery

Valve disease is either stenosis (a valve that doesn't open fully, obstructing flow) or regurgitation (a valve that doesn't close fully, allowing backflow). The two valves operated on most often are the mitral and aortic valves.

Repair vs replacement: repair is preferred whenever feasible, especially for mitral regurgitation from prolapse, because it preserves the native valve architecture, avoids lifelong anticoagulation, and carries a lower infection risk. Replacement becomes necessary when the valve tissue is too damaged or calcified to reconstruct — this is common in aortic stenosis from calcific degeneration.

Mechanical vs bioprosthetic valves: mechanical valves are extremely durable (decades) but require lifelong warfarin because they trigger clot formation on contact with blood. Bioprosthetic (tissue) valves don't require long-term anticoagulation but degenerate over 10-15 years, especially in younger patients. The choice depends heavily on age and the patient's ability to manage anticoagulation — younger patients often accept a mechanical valve's durability, while older patients or those who can't safely anticoagulate get a bioprosthetic valve.

Minimally invasive options: transcatheter aortic valve implantation (TAVI/TAVR) delivers a valve via catheter (usually through the femoral artery) without opening the chest, and has become standard for high- and intermediate-surgical-risk aortic stenosis patients.

Thoracic Surgery for Lung Cancer

Surgical resection is the primary curative treatment for early-stage (Stage I-II, and select Stage IIIA) non-small cell lung cancer.

Extent of resection is chosen to balance oncologic completeness against preserving lung function:

• Lobectomy (removal of one lobe) is the standard of care for most resectable tumors confined to a single lobe
• Pneumonectomy (removal of an entire lung) is reserved for centrally located tumors that can't be cleared by a lesser resection
• Segmentectomy or wedge resection (removing less than a full lobe) is used for small peripheral tumors or in patients with poor pulmonary reserve who cannot tolerate a lobectomy, accepting a higher local recurrence risk in exchange for preserving lung function

Regardless of the extent of resection, mediastinal lymph node sampling or dissection is mandatory — it stages the cancer accurately and guides the need for adjuvant chemotherapy. Video-assisted thoracoscopic surgery (VATS) and robotic approaches have largely replaced open thoracotomy for anatomic lung resections, reducing pain, hospital stay, and complications while achieving equivalent oncologic outcomes.

Key Terms

Term	Definition
Cardiopulmonary bypass (CPB)	A machine that temporarily takes over the heart's pumping and the lungs' oxygenation function, allowing surgery on a still, bloodless heart
Cardioplegia	A potassium-rich solution infused into the coronary circulation to stop the heart in a relaxed (diastolic) state, protecting it from ischemic injury during bypass
LIMA graft	Left internal mammary artery used as a bypass conduit, most commonly to the LAD; the most durable graft in CABG
Patency	The proportion of grafts or repairs that remain open and functional over time; the key long-term outcome measure for bypass grafts and repairs
Valve regurgitation	Backward leakage of blood through a valve that fails to close completely
Valve stenosis	Narrowing of a valve opening that obstructs forward blood flow
TAVI/TAVR	Transcatheter aortic valve implantation/replacement; a catheter-based, non-surgical technique for replacing the aortic valve
Lobectomy	Surgical removal of one lobe of the lung, the standard operation for early-stage lung cancer confined to one lobe
VATS	Video-assisted thoracoscopic surgery; a minimally invasive approach to thoracic operations using a camera and small incisions
Mediastinal lymph node dissection	Removal/sampling of lymph nodes in the mediastinum during lung cancer surgery for accurate staging

Common Mistakes

1. Misconception: "CABG cures coronary artery disease." Why it's wrong: CABG bypasses the blocked segments but does not treat the underlying atherosclerotic process affecting the rest of the coronary tree or the new grafts themselves. Correct explanation: CABG relieves ischemia and improves survival in appropriate patients, but lifelong risk factor control (statins, blood pressure, smoking cessation, diabetes management) is essential to prevent disease progression and graft failure.

2. Misconception: "A mechanical heart valve is always the better choice because it lasts longer." Why it's wrong: Durability is only one factor; mechanical valves require lifelong warfarin anticoagulation, which carries its own bleeding risk and lifestyle burden. Correct explanation: Valve choice is individualized — younger patients who can safely manage anticoagulation often get mechanical valves, while older patients or those with contraindications to anticoagulation (e.g., high fall risk, pregnancy plans) usually receive a bioprosthetic valve despite its shorter lifespan.

3. Misconception: "Pneumonectomy is the safest option for lung cancer because it removes the most tissue." Why it's wrong: Removing more lung than necessary increases perioperative mortality and long-term respiratory disability without improving cure rates when a lesser resection would achieve clear margins. Correct explanation: The extent of resection is matched to tumor location and size — lobectomy is preferred whenever it achieves oncologic clearance, and pneumonectomy is reserved only for centrally located tumors that cannot otherwise be removed completely.

Comparison and Connections

Feature	CABG	Valve Surgery (replacement)	Lung Resection (lobectomy)
Primary goal	Restore myocardial blood flow	Restore normal valve function	Remove tumor with clear margins
Uses cardiopulmonary bypass?	Usually (or off-pump alternative)	Yes, almost always	No
Key decision point	Graft conduit selection	Mechanical vs bioprosthetic valve	Extent of resection vs lung reserve
Minimally invasive option	Off-pump / robotic CABG	TAVI/TAVR (catheter-based)	VATS / robotic thoracoscopic surgery
Major long-term concern	Graft patency	Valve durability / anticoagulation	Local recurrence / lung function

Practice Questions

Recall

1. What conduit is preferred for grafting to the LAD in CABG, and why? Answer guidance: The LIMA, because it has the highest long-term patency (>90% at 10 years) due to its resistance to atherosclerosis compared with vein grafts.

2. Name the two broad categories of prosthetic heart valves. Answer guidance: Mechanical valves and bioprosthetic (tissue) valves.

Understanding

3. Explain why off-pump CABG might be chosen over on-pump CABG for a particular patient. Answer guidance: Off-pump avoids cardiopulmonary bypass, reducing risks of stroke, systemic inflammatory response, and bleeding-related complications, which is particularly beneficial in patients with calcified aortas or other high-risk features — at the cost of a technically more demanding operation.

4. Why is mediastinal lymph node sampling performed during every anatomic lung resection for cancer, even when nodes appear normal on imaging? Answer guidance: Imaging can miss microscopic nodal disease; accurate pathological staging determines prognosis and whether adjuvant chemotherapy is needed.

Application

5. A 45-year-old patient with severe mitral regurgitation from a prolapsed posterior leaflet is being considered for surgery. What operation would you recommend and why? Answer guidance: Mitral valve repair, because prolapse-related regurgitation is typically very amenable to repair, which avoids anticoagulation and has better long-term outcomes than replacement in this scenario.

6. A patient with poor pulmonary function tests has a small, peripheral early-stage lung tumor. What surgical option balances cancer control with preserving lung function? Answer guidance: Segmentectomy or wedge resection, since it removes less lung tissue than a lobectomy while still addressing a small peripheral tumor, accepting a modestly higher local recurrence risk.

Analysis

7. Compare the long-term trade-offs of using a saphenous vein graft versus a radial artery graft in CABG. Answer guidance: The vein graft is easier to harvest and handle but has lower 10-year patency due to intimal hyperplasia and atherosclerosis; the radial artery has better long-term patency but is prone to spasm, requiring postoperative calcium channel blockers, and is technically harder to harvest.

8. A 78-year-old with severe aortic stenosis is deemed high surgical risk. Analyze why TAVI might be favored over open surgical aortic valve replacement. Answer guidance: TAVI avoids sternotomy and cardiopulmonary bypass, reducing perioperative morbidity in a frail, high-risk patient, while still relieving the valve obstruction — though durability data in younger, lower-risk patients is still maturing compared with surgical valves.

FAQ

Q1: Why is the LIMA preferred over a vein for the most important coronary graft? Because arterial grafts like the LIMA are biologically resistant to the atherosclerosis that eventually damages vein grafts, giving them dramatically better long-term patency, especially when placed to the LAD, the most clinically important vessel.

Q2: Can a repaired valve fail later and need replacement? Yes. Repairs can degenerate over time, particularly if the underlying pathology (like severe leaflet prolapse or annular dilation) recurs, but repair still generally outperforms replacement in terms of durability and avoiding anticoagulation when the anatomy is favorable.

Q3: Why do some CABG patients need anticoagulation and others don't? CABG itself doesn't require long-term anticoagulation — patients are typically on antiplatelet therapy (aspirin, sometimes with a second agent). Anticoagulation with warfarin becomes necessary only if a mechanical valve was also placed or another indication (like atrial fibrillation) exists.

Q4: Is VATS as effective as open thoracotomy for lung cancer? Yes, multiple studies show VATS achieves equivalent oncologic outcomes (survival, recurrence) to open thoracotomy for early-stage lung cancer, while reducing pain, blood loss, hospital stay, and complications.

Q5: What determines whether a patient gets a lobectomy versus a smaller resection? Tumor size, location, and the patient's pulmonary reserve. Lobectomy is the oncologic standard when the patient can tolerate it; a sublobar resection (segmentectomy/wedge) is chosen when pulmonary function is too limited to safely remove a full lobe.

Quick Revision

• CABG bypasses blocked coronary arteries; it doesn't cure atherosclerosis — risk factor control is still essential
• LIMA to LAD is the gold-standard graft, with over 90% patency at 10 years
• Saphenous vein grafts have lower long-term patency than arterial grafts due to intimal hyperplasia
• Cardioplegia stops the heart in diastole to protect it during cardiopulmonary bypass
• Off-pump CABG avoids bypass-related complications but is technically demanding
• Valve repair is preferred over replacement when feasible (avoids anticoagulation, better durability)
• Mechanical valves last longer but require lifelong warfarin; bioprosthetic valves avoid anticoagulation but wear out in 10-15 years
• TAVI is a catheter-based alternative to open aortic valve replacement, used mainly in high/intermediate-risk patients
• Lobectomy is the standard resection for early-stage lung cancer confined to one lobe
• Pneumonectomy is reserved for centrally located tumors not resectable by a lesser operation
• Mediastinal lymph node sampling is mandatory in lung cancer surgery for accurate staging
• VATS/robotic approaches now dominate over open thoracotomy, with equivalent oncologic outcomes and faster recovery

Related Topics

Prerequisites: Basic cardiac anatomy and coronary circulation, cardiac physiology (cardiac cycle, valve function), and general principles of anesthesia for major surgery.

Related Topics: Ischemic heart disease and its medical management, principles of anesthesiology in cardiothoracic procedures, general orthopedic and surgical postoperative care.

Next Topics: Vascular surgery, transplant surgery (heart and lung transplantation), and critical care management of the postoperative cardiothoracic patient.